Details of the Drug
General Information of Drug (ID: DMP0NW3)
Drug Name |
2-phenyl-N-(thiazol-2-yl)acetamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-Phenyl-N-(1,3-thiazol-2-yl)acetamide; 2-Phenyl-N-thiazol-2-yl-acetamide; 292051-66-2; Benzeneacetamide, N-2-thiazolyl-; BAS 15431504; ChemDiv2_003476; AC1LBQ73; MLS001211116; CHEMBL227897; SCHEMBL4687548; ZINC29573; HYRZQLIFVQELLP-UHFFFAOYSA-N; MolPort-001-012-138; HMS2829M16; HMS1378N22; STK012295; AKOS000714854; MCULE-4931151694; ST042627; SMR000516648; 2-Phenyl-N-(1,3-thiazol-2-yl)acetamide #; 2-phenyl-N~1~-(1,3-thiazol-2-yl)acetamide; SR-01000415900; SR-01000415900-1; BRD-K98487211-001-07-7; Z28173686
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 218.28 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||